Related Experiment Video
Updated: Oct 12, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Iron Metabolism as a Potential Mechanism for Inducing TRAIL-Mediated Extrinsic Apoptosis Using Methylsulfonylmethane
Nipin Sp1, Dong Young Kang1, Eun Seong Jo2
1Department of Pathology, Institute of Biomedical Science and Technology, School of Medicine, Konkuk University, Chungju 27478, Korea.
Abstract:
Embryonic cancer stem cells (CSCs) can differentiate into any cancer type. Targeting CSC using natural compounds is a good approach as it suppresses cancer recurrence with fewer adverse effects, and methylsulfonylmethane (MSM) is a sulfur-containing compound with well-known anticancer activities. This study determined the mechanistic aspects of the anticancer activity of MSM. We used Western blotting and real-time qPCR for molecular signaling studies and conducted flow cytometry for analyzing the processes in cells. Our results suggested an inhibition in the expression of CSC markers and Wnt/β-catenin signaling. MSM induced TRAIL-mediated extrinsic apoptosis in NCCIT and NTERA-2 cells rather than an intrinsic pathway. Inhibition of iron metabolism-dependent reactive oxygen species (ROS) generation takes part in TRAIL-mediated apoptosis induction by MSM. Suppressing iron metabolism by MSM also regulated p38/p53/ERK signaling and microRNA expressions, such as upregulating miR-130a and downregulating miR-221 and miR-222, which resulted in TRAIL induction and thereby extrinsic pathway of apoptosis. Hence, MSM could be a good candidate for neoadjuvant therapy by targeting CSCs by inhibiting iron metabolism.
Insights
Methylsulfonylmethane (MSM) targets embryonic cancer stem cells (CSCs) by inhibiting iron metabolism, inducing TRAIL-mediated apoptosis. This natural compound shows promise for neoadjuvant therapy by suppressing CSCs and reducing cancer recurrence.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Embryonic cancer stem cells (CSCs) possess the potential to differentiate into various cancer types, contributing to tumor recurrence.
- Natural compounds offer a promising avenue for targeting CSCs with reduced adverse effects.
- Methylsulfonylmethane (MSM), a sulfur-containing compound, exhibits known anticancer properties.
Purpose of the Study:
- To elucidate the mechanistic anticancer effects of methylsulfonylmethane (MSM) on embryonic cancer stem cells (CSCs).
- To investigate MSM's impact on CSC markers and associated signaling pathways.
- To determine the specific apoptotic pathway induced by MSM in cancer cells.
Main Methods:
- Western blotting and real-time quantitative PCR (qPCR) were employed for molecular signaling analysis.
- Flow cytometry was utilized to analyze cellular processes.
- Specific CSC markers, Wnt/β-catenin signaling, and apoptosis pathways were assessed.
Main Results:
- MSM significantly inhibited the expression of CSC markers and suppressed Wnt/β-catenin signaling.
- MSM induced TRAIL-mediated extrinsic apoptosis in NCCIT and NTERA-2 cells, bypassing the intrinsic pathway.
- MSM's inhibition of iron metabolism-dependent reactive oxygen species (ROS) generation was crucial for TRAIL-mediated apoptosis induction.
- MSM modulated p38/p53/ERK signaling and microRNA expression (upregulating miR-130a, downregulating miR-221/222), leading to TRAIL induction.
Conclusions:
- MSM effectively targets embryonic cancer stem cells (CSCs) by inhibiting iron metabolism.
- MSM induces apoptosis through the TRAIL-mediated extrinsic pathway, offering a novel therapeutic strategy.
- MSM demonstrates potential as a neoadjuvant therapy agent for cancer by targeting CSCs and their iron metabolism.
More Related Videos
10:39Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mesenchymal Stem Cells
The Intrinsic Apoptotic Pathway